Given that GLUT-1 expression is upregulated by AKT activation [21] and we have shown CCL5 activation of AKT, we examined the effects of CCL5 treatment on GLUT-1 cell surface expression for the different breast cancer cells. This evidence concerns the gene SLC2A1 and breast carcinoma.